Coya Therapeutics News

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA)

TipRanksMar 20 06:01 ET

Coya Therapeutics Analyst Ratings

BenzingaMar 20 05:29 ET

Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Edwards Lifesciences (EW) and Coya Therapeutics, Inc. (COYA)

TipRanksFeb 14 06:41 ET

Buy Rating Affirmed for Coya Therapeutics Amid Promising Drug Development and Regulatory Milestones

TipRanksJan 31 21:26 ET

BTIG Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)

TipRanksJan 7 05:27 ET

Buy Rating on Coya Therapeutics: Boosted Cash Reserves and Promising Development in Drug Research

TipRanksNov 8, 2023 16:56 ET

Buy Rating Endorsed for Coya Therapeutics: Promising Therapeutic Advancements and Strong IP Portfolio

TipRanksOct 13, 2023 07:46 ET

Positive Outlook for Coya Therapeutics: Novel Alzheimer's Treatments and Strategic Growth Initiatives Drive Buy Rating

TipRanksOct 9, 2023 18:35 ET

Coya Therapeutics, Inc. (COYA) Gets a Buy From Chardan Capital

TipRanksSep 1, 2023 07:55 ET

Coya Therapeutics Analyst Ratings

BenzingaAug 9, 2023 04:39 ET

EF Hutton Reiterates Buy on Coya Therapeutics, Maintains $28 Price Target

BenzingaJul 18, 2023 04:08 ET

Coya Therapeutics Analyst Ratings

BenzingaJul 18, 2023 04:08 ET

Coya Therapeutics Analyst Ratings

BenzingaJul 17, 2023 12:29 ET

Coya Therapeutics, Inc. (COYA) Gets a Buy From BTIG

TipRanksJun 20, 2023 20:35 ET

The Latest Analyst Ratings for Coya Therapeutics

BenzingaJun 8, 2023 12:00 ET

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $11

BenzingaJun 8, 2023 05:20 ET

Coya Therapeutics, Inc. (COYA) Receives a Buy From Chardan Capital

TipRanksJun 7, 2023 18:55 ET

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Guardant Health (GH) and Coya Therapeutics, Inc. (COYA)

TipRanksJun 7, 2023 18:30 ET

Analysts Conflicted on These Healthcare Names: Coya Therapeutics, Inc. (COYA) and Harmony Biosciences Holdings (HRMY)

TipRanksJun 7, 2023 16:30 ET

EF Hutton Reiterates Buy on Coya Therapeutics, Maintains $28 Price Target

BenzingaJun 7, 2023 13:45 ET